---
title: "投資者截止日期即將到來：Faruqi & Faruqi, LLP 正在代表 RxSight 的投資者調查索賠"
description: "投資者截止日期臨近：Faruqi & Faruqi, LLP 正在代表投資者調查索賠"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258195322.md"
published_at: "2025-09-20T14:06:47.000Z"
---

# 投資者截止日期即將到來：Faruqi & Faruqi, LLP 正在代表 RxSight 的投資者調查索賠

> 投資者截止日期臨近：Faruqi & Faruqi, LLP 正在代表投資者調查索賠

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...

### Related Stocks

- [RXST.US - RxSight](https://longbridge.com/zh-HK/quote/RXST.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 09:37 ETSHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyndryl Holdings | Faruqi & Faruqi, LLP is investigating potential claims against Kyndryl Holdings, Inc. following significant losses in it | [Link](https://longbridge.com/zh-HK/news/275622239.md) |
| 10:18 ETINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics | Faruqi & Faruqi, LLP is investigating potential claims against Beta Bionics, Inc. following a significant drop in its st | [Link](https://longbridge.com/zh-HK/news/275920576.md) |
| 10:23 ETINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics | Faruqi & Faruqi, LLP is investigating potential claims on behalf of investors in Aquestive Therapeutics, Inc. following  | [Link](https://longbridge.com/zh-HK/news/275920901.md) |
| 10:04 ETQURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 | Faruqi & Faruqi, LLP is investigating potential claims against uniQure N.V. and reminds investors of the April 13, 2026  | [Link](https://longbridge.com/zh-HK/news/275775526.md) |
| QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 | Faruqi & Faruqi, LLP reminds investors of uniQure (QURE) about the April 13, 2026 deadline to seek lead plaintiff status | [Link](https://longbridge.com/zh-HK/news/275654673.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。